Menu

Innovation

May 14, 2026 • In the News

TrialSite News: Could a Blood Test Detect Alzheimer’s Earlier Than Brain Scans? 

Could Alzheimer’s disease one day be detected with a simple blood test instead of expensive brain scans? In this episode of the TrialSite News Farago Podcast, we speak with John Dwyer, President and CEO of the Global Alzheimer’s Platform Foundation (GAP), about the Bio-Hermes-002 study and the future of Alzheimer’s detection. The conversation explores how […]

Alzheimer's Alzheimers Bio-Hermes Bio-Hermes-002 biomarkers Innovation Research
April 29, 2026 • In the News

Newsbreak: Experts share updates on memory and aging

Representatives from Butler Hospital’s Memory and Aging Program and the Global Alzheimer’s Platform recently visited the Swansea Council on Aging to discuss normal memory changes with age and new research in Alzheimer’s prevention. The session also encouraged residents to engage with the Acti-v8 initiative and join a prevention registry. This content is adapted from materials provided by Swansea Council On Aging This article includes […]

Alzheimer's Alzheimers GAP Innovation Research
April 22, 2026 • In the News

PR NewsWire: Re:Cognition Health Delivers Landmark International Clinical Trial to Explore Whether a Simple Finger-prick Blood-based Biomarker Test Can Provide Earlier Alzheimer’s Diagnosis

Houston, Texas (April 15, 2026) – Re:Cognition Health, a global leader in new treatments for Alzheimer’s Disease, is delivering an international clinical trial to evaluate whether a simple finger-prick blood test can revolutionize how Alzheimer’s disease is diagnosed. Compared with the current invasive and expensive diagnostic methods, this approach could provide a scalable solution for […]

Alzheimer's Bio-Hermes-002 GAP Innovation LifeArc Research
April 10, 2026 • In the News

Voices of Healthcare: GAP, Siemens Healthineers Partner for Bio-Hermes-002 Alzheimer’s Study

The Global Alzheimer’s Platform Foundation (GAP) has announced a strategic collaboration with Siemens Healthineers for the Bio-Hermes-002 study, an observational platform designed to evaluate biomarkers for Alzheimer’s disease and related dementias. The study compares blood-based and digital biomarkers across a wide range of cognitive conditions, alongside MRI and PET imaging data, to generate insights that […]

Alzheimer's Alzheimers Bio-Hermes-002 GAP Innovation Research Siemens Healthineers
April 7, 2026 • Letter from the President

GAP’s 2026 Q1 Highlights

Colleagues, Trusted Partners, & Friends, We want to share a brief update on how Q1 of 2026 unfolded for the Global Alzheimer’s Platform Foundation (GAP) and the significant work anticipated ahead.  In January, our work received global coverage as the British Broadcasting Corporation (BBC) spotlighted the Bio-Hermes-002 (BH2) study in a story about a finger prick blood test […]

Alzheimer's GAP Innovation Research
March 27, 2026 • Press Releases

Axiom Brain Health’s Dr. Susan Steen to be Honored at Inspire, Imagine, and Hope Gala on Friday

Tampa, FL, Mar 25, 2026—  Axiom Brain Health (Axiom) is pleased to announce Dr. Susan Steen will be honored by the Alzheimer’s Association – Florida Gulf Coast Chapter at the Inspire, Imagine, and Hope Gala on Friday, March 27, 2026, at The Gathering @ Armature Works in Tampa. “I am delighted to receive this honor from the […]

Alzheimer's Alzheimers GAP Innovation Research
February 27, 2026 • Press Releases

Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts

The Global Alzheimer’s Platform Foundation’s® (GAP) 2025 Citizen Scientist Award® recipients announced in Las Vegas WASHINGTON, DC (Feb. 27, 2026) — Today, the Global Alzheimer’s Platform Foundation (GAP) proudly announced the 2025 National Citizen Scientist Awards® elevated honorees. GAP’s Citizen Scientist Awards (CSA) acknowledge the contributions of individuals who make a difference by volunteering in clinical trials for neurodegenerative diseases.  This year’s award […]

Alzheimer's Alzheimers Citizen Scientist Awards GAP Innovation Research
February 25, 2026 • In the News

Archynewsy: Alzheimer’s Research Advances: Global Alzheimer’s Platform Foundation Conference in Las Vegas

Las Vegas is set to host a significant gathering of Alzheimer’s and Parkinson’s disease research leaders this week, as the Global Alzheimer’s Platform Foundation (GAP) convenes its annual conference from February 25th through February 27th at the Red Rock Casino Resort & Spa. The event will bring together nearly 250 representatives from over 100 clinical […]

Alzheimer's Alzheimers GAP Innovation Research
February 24, 2026 • In the News

3 News Las Vegas: Global Alzheimer’s Platform Foundation event happening at Red Rock Casino

by Chloe KoastTue, February 24, 2026 at 9:36 AM From February 25th through the 27th the Global Alzheimer’s Platform Foundation will meet up at the Red Rock Casino Resort & Spa. More than 250 representatives are coming together to not only network but also share their dedication to find the cure for Alzheimer’s. This includes announcing a new […]

Alzheimers GAP Innovation Research
February 18, 2026 • In the News

Medical Product Outsourcing: Could a Finger Prick Blood Test Help Diagnose Alzheimer’s?

The disease currently is diagnosed using expensive scans and lumbar punctures or spinal taps. February 18, 2026 By: Michael Barbella Managing Editor Alzheimer’s disease detection could be quite literally at our fingertips. A major international research project is underway at the U.K. Dementia Research Institute (DRI) to test whether a finger prick-style blood test could be […]

Alzheimer's Alzheimers Bio-Hermes-002 biomarkers GAP Innovation Research